The hypoxia-inducible factor HIF-1 promotes intramyocardial expression of VEGF in infants with congenital cardiac defects

Basic Research in Cardiology

Volumn 102, Issue 3, 2007, Pages 224-232

  Quing, Ma ^a   Görlach, Agnes ^b   Schumacher, Kathrin ^a   Wötje, Michael ^a   Vazquez Jimenez, Jaime F ^a   Hess, John ^b   Seghaye, Marie Christine ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

eNOS; Hypoxemia; Hypoxia inducible factor HIF; Infants with congenital cardiac defects; VEGF

Indexed keywords

DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; VASCULOTROPIN;

ARTICLE; CHRONIC DISEASE; CLAMP; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CYANOSIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE TARGETING; HEART MUSCLE BIOPSY; HEART SURGERY; HEART VENTRICLE; HUMAN; HUMAN TISSUE; HYPOXEMIA; IMMUNOCYTOCHEMISTRY; INFANT; MALE; PROTEIN DNA BINDING; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CYANOSIS; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; INFANT; INFANT, NEWBORN; MALE; MYOCARDIUM; NITRIC OXIDE SYNTHASE; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34147093240     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-007-0639-2     Document Type: Article

References (36)

1. Andrews NC, Faller DV (1991) A rapid micro preparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499
2. BelAiba RS, Djordjevic T, Bonello S, Flugel D, Hess J, Kietzmann T, Gorlach A(2004) Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells. Biol Chem 385:249-257
3. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, Sugden PH (1996) Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RKmitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 79:162-173
4. Burton PB, Owen VJ, Hafizi S, Barton PJ, Carr-White G, Koh T, De Souza A, Yacoub MH, Pepper JR (2000) Vascular endothelial growth factor release following coronary artery bypass surgery: Extra corporeal circulation versus 'beating heart' surgery. Eur Heart J 21:1708-1713
5. Coulet F, Nadaud S, Agrapart M, Soubrier F (2003) Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 278:46230-46240
6. Couvelard A, O'Toole D, Leek R, Turley H, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter K, Pezzella F (2005) Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adeno carcinomas.Histopathology 46:668-676
7. Felaco M, Grilli A, Gorbunov N, DiNapoli P, De Lutiis MA, Di Giulio C, Taccardi AA, Barsotti A, Barbacane RC, Reale M, Conti P (2000) Endothelial NOS expression and ischemia-reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions. Biochim Biophys Acta 1524:203-211
8. Feng Q, Song W, Lu X, Hamilton JA, Lei M, Peng T, Yee SP (2002) Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 106:873-879
9. Ferrara N (2004) Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 25:581-611
10. Ferreiro CR, Chagas AC, Carvalho MH, Dantas AP, Jatene MB, Bento De SouzaL C, Lemos Da Luz P (2001) Influence of hypoxia on nitric oxide synthase activity and gene expression in children with congenital heart disease: A novel pathophysiological adaptive mechanism. Circulation 103:2272-2276
11. Forkel J, Chen X, Wandinger S, Keser F, Duschin A, Schwanke U, Frede S, Massoudy P, Schulz R, Jakob H, Heusch G (2004) Responses of chronically hypoxic rat hearts to ischemia: KATP channel blockade does not abolish increased RV tolerance to ischemia. Am J Physiol Heart Circ Physiol 286:545-551
12. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK (2001) Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A 98:2604-2609
13. Giordano FJ, Gerber HP, Williams SP, VanBruggen N, Bunting S, Ruiz-Lozano P, Gu Y, Nath AK, Huang Y, Hickey R, Dalton N, Peterson KL, Ross J, Jr., Chien KR, Ferrara N (2001) A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci USA 98:5780-5785
14. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, Busse R (2001) Thrombin activates the hypoxia inducible factor-1 signaling pathway invascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res 89:47-54
15. Hellwig-Burgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W (2005) Review:hYpoxia-inducible factAr-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 25:297-310
16. Himeno W, Akagi T, Furui J, Maeno Y, Ishii M, Kosai K, Murohara T, Kato H (2003) Increased angiogenic growth factor in cyanotic congenital heart disease. Pediatr Cardiol 24:127-132
17. Hood JD, Meininger CJ, Ziche M, Granger HJ (1998) VEGF upregulate sec NOS message, protein, and NO production in human endothelial cells. Am J Physiol 274:1054-1058
18. Hu J, Sun P, Ruan X, Chao A, Lin Y, Li XY(2005) Mechanism of myocardial microvessel formation in cyanotic congenital heart disease. Circ J 69:1089-1093
19. Jurgensen JS, Rosenberger C, Wiesener MS, Warnecke C, Horstrup JH, Grafe M, Philipp S, Griethe W, Maxwell PH, Frei U, Bachmann S, Willenbrock R, Eckardt KU (2004) Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardium. Faseb J 18:1415-1417
20. Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW, Thistlethwaite PA(2005) Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol 46:2116-2124
21. Kietzmann T, Gorlach A (2005) Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 16:474-486
22. Kietzmann T, Jungermann K, Gorlach A(2003) Regulation of the hypoxia-dependent plasminogen activator inhibitor1 expression by MAP kinases.Thromb Haemost 89:666-673
23. Kim CH, Cho YS, Chun YS, Park JW,Kim MS (2002) Early expression of myocardial HIF-1alpha in response to mechanical stresses: Regulation by stretch-activated channels and the phosphatidyl inositol 3-kinase signaling pathway. Circ Res 90:25-33
24. Lee SH, Wolf PL, Escudero R, Deutsch R,Jamieson SW, Thistlethwaite PA (2000)Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342:626-633
25. Mazure NM, Brahimi-Horn MC, Pouyssegur J (2003) Protein kinases and the hypoxia-inducible factor-1, two switches in angiogenesis. Curr Pharm Des 9:531-541
26. Namba T, Koike H, Murakami K, AokiM, Makino H, Hashiya N, Ogihara T, Kaneda Y, Kohno M, Morishita R (2003) Angiogenesis induced by endothelia lnitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation 108:2250-2257
27. Parisi Q, Biondi-Zoccai GG, Abbate A, Santini D, Vasaturo F, Scarpa S, BussaniR, Leone AM, Petrolini A, Silvestri F, Biasucci LM, Baldi A (2005) Hypoxia inducible factor-1 expression mediates myocardial response to ischemia late after acute myocardial infarction. Int J Cardiol 99:337-339
28. Philipp S, Cui L, Ludolph B, Kelm M, Schulz R, Cohen MV, Downey JM (2006)Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS. Am J Physiol Heart Circ Physiol 290:450-457
29. Qing M, Schumacher K, Heise R, WoltjeM, Vazquez-Jimenez JF, Richter T, Arranda-Carrero M, Hess J, von BernuthG, Seghaye MC (2003) Intramyocardial synthesis of pro- and anti-inflammatory cytokines in infants with congenital cardiac defects. J Am Coll Cardiol 41:2266-2274
30. Rapino C, Bianchi G, Di Giulio C, Centurione L, Cacchio M, Antonucci A, Cataldi A (2005) HIF-1alpha cytoplasmic accumulation is associated with cell death in old rat cerebral cortex exposed to intermittent hypoxia. Aging Cell 4:177-185
31. Semenza GL (2004) O2-regulated gene expression: Transcriptional control of cardio respiratory physiology by HIF-1.J Appl Physiol 96:1173-1177; discussion1170-1172
32. Shyu KG, Wang MT, Wang BW, Chang CC, Leu JG, Kuan P, Chang H (2002) Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Cardiovasc Res 54:576-583
33. Starnes SL, Duncan BW, Kneebone JM, Rosenthal GL, Jones TK, Grifka RG, Cecchin F, Owens DJ, Fearneyhough C, Lupinetti FM (2000) Vascular endothelial growth factor and basic fibroblast growth factor in children with cyanotic congenital heart disease. J Thorac Cardiovasc Surg 119:534-539
34. Tammela T, Enholm B, Alitalo K, PaavonenK (2005) The biology of vascular endothelial growth factors. Cardiovasc Res 65:550-563
35. Tomanek RJ, Zheng W, Yue X (2004)Growth factor activation in myocardial vascularization: Therapeutic implications. Mol Cell Biochem 264:3-11
36. Zhao X, Lu X, Feng Q (2002) Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis. Am J Physiol Heart Circ Physiol 283:2371-2378